Process for the preparation of steroids bearing
17.alpha.-hydroxy-20-oxopregnane side chain
    7.
    发明授权
    Process for the preparation of steroids bearing 17.alpha.-hydroxy-20-oxopregnane side chain 失效
    制备支链17(ALPHA) - 羟基-20-氧化二苯胺侧链的方法

    公开(公告)号:US5241063A

    公开(公告)日:1993-08-31

    申请号:US717823

    申请日:1991-06-19

    IPC分类号: C07J7/00 C07J21/00

    CPC分类号: C07J7/0045 C07J21/00

    摘要: The invention relates to a novel process for the preparation of 17 .alpha.-hydroxy-20-oxopregnane derivatives of the general formula (I), ##STR1## wherein R.sub.1 means a hydroxy or an oxo group; andthe dotted lines optionally represent one or more additional valence bond(s), with the proviso that the dotted line in the 4-position and the dotted line in the 5-position cannot each simultaneously be an additional valence bond from steroids having 23,24-dinor-17(20)-dehydrocholan-22-oic -22-oic acid structure.According to the process of the invention a steroid derivative having 23,24-dinorcholan-22-oic acid structure, containing a double bond in 17(20)-position, is transformed to 17.alpha., 20-epoxy-23,24-dinorcholanoic acid, the latter is converted to a reactive acid derivative, which is then reacted with a salt-containing azide ion to yield a 17.alpha., 20-epoxy-23,24-dinorcholanoic acyl azide derivative and the azide obtained is reacted with a mineral or organic acid in an aqueous medium.

    摘要翻译: 本发明涉及制备通式(I)的17α-羟基-20-氧代孕烷衍生物的新方法,其中R1表示羟基或氧代基; 并且虚线可选地表示一个或多个另外的价键,条件是4-位中的虚线和5-位的虚线不能同时作为具有23的类固醇的另外的价键, 24-二酮-17(20) - 脱氢胆烷-22-酸-22-酸结构。 根据本发明的方法,在17(20) - 位中含有双键的具有23,24-二肌醇二十二酸结构的类固醇衍生物转化为17α,20-环氧-23,24-二肉桂酸 酸,后者转化为反应性酸衍生物,然后与含盐的叠氮化物离子反应,得到17α,20-环氧-23,24-二牛油酰基叠氮化物衍生物,所得叠氮化物与矿物质反应 或有机酸。

    16-Amino-postaglandin derivatives, their acid addition salts, and a
process for the preparation thereof
    10.
    发明授权
    16-Amino-postaglandin derivatives, their acid addition salts, and a process for the preparation thereof 失效
    16-氨基 - Postaglandin衍生物及其酸加成盐及其制备方法

    公开(公告)号:US4372973A

    公开(公告)日:1983-02-08

    申请号:US332840

    申请日:1981-12-21

    摘要: The invention relates to new 16-amino-prostaglandin derivatives of general formula I, ##STR1## wherein C-15 and C-16 may have either S or R configuration, Z stands for a hydrogen atom or a lower alkyl group, and their acid addition salts. These compounds can be prepared by removing the ester group and the p-nitrocarbobenzyloxy protective group of a 9.alpha., 11.alpha., 15-trihydroxy-16-p-nitrobenzyloxycarbonylamido-5-cis,13-trans-prostadienoic acid derivative of general formula XII--wherein C-15 and C-16 may have either S or R configuration and Z stands for a lower alkyl group--in an optional sequence with the limitation that in those compounds of general formula I where Z stands for a lower alkyl group solely the p-nitrocarbobenzyloxy group is removed, and the resulting product of general formula I is optionally converted with an organic or inorganic acid into a salt.The new prostaglandin derivatives of the invention have valuable therapeutical properties, and can be applied as abortive or oxytocic agents.

    摘要翻译: 本发明涉及通式I的新的16-氨基前列腺素衍生物,其中C-15和C-16可以具有S或R构型,Z代表氢原子或低级烷基,它们的酸 加成盐。 这些化合物可以通过除去通式9的9α,11α,15-三羟基-16-对硝基苄氧基羰基酰胺基-5-顺式,13-反式 - 前列腺烯酸衍生物的酯基和对硝基苄氧基保护基来制备 XII-其中C-15和C-16可以具有S或R构型,Z表示低级烷基 - 在任选的序列中,限制在通式I的那些化合物中,其中Z仅代表低级烷基 除去对硝基羰基苄氧基,将所得的通式I的产物任选地用有机或无机酸转化成盐。 本发明的新型前列腺素衍生物具有有价值的治疗性质,可用作流产或催产素。